Investing

Canadian Small caps and Penny stocks

  • Last Updated:
  • May 11th, 2023 8:36 am
Tags:
None
Deal Fanatic
User avatar
May 2, 2006
8355 posts
2268 upvotes
GTA
Exited GGG @ .09 and RLV @ .05. Need to see where they settle before playing again or until the next update.

NSP & GSI see the bids continually moving up. Very nice action!

Added DOC @ .425 to average down a bit.
Deal Addict
Apr 20, 2018
1033 posts
187 upvotes
Oakville, ON
izzyzz wrote: Exited GGG @ .09 and RLV @ .05. Need to see where they settle before playing again or until the next update.

NSP & GSI see the bids continually moving up. Very nice action!

Added DOC @ .425 to average down a bit.
should have held RLV

They just put their hand sanitizer on the site today... already sold out

https://www.bioganix.com/products/clean ... -sanitizer
Deal Addict
Nov 14, 2006
3149 posts
1952 upvotes
GTA
raptors87 wrote: should have held RLV

They just put their hand sanitizer on the site today... already sold out

https://www.bioganix.com/products/clean ... -sanitizer
Its down so you can jump back in

EDIT:

Big wall at 0.04 to keep it down

Code: Select all

Level II Quotes
Orders	Shares	Bid	Ask	Shares	Orders
13	273,000	0.045	0.05	513,000	12
31	2,047,000	0.04	0.055	531,000	13
17	1,487,000	0.035	0.06	679,000	17
8	1,121,000	0.03	0.065	1,100,000	18
6	357,000	0.025	0.07	1,548,000	36
Deal Addict
Apr 20, 2018
1033 posts
187 upvotes
Oakville, ON
should have clarify lol ...I meant izzyzz

how did you get those information?
lilmikey wrote: Its down so you can jump back in

EDIT:

Big wall at 0.04 to keep it down

Code: Select all

Level II Quotes
Orders	Shares	Bid	Ask	Shares	Orders
13	273,000	0.045	0.05	513,000	12
31	2,047,000	0.04	0.055	531,000	13
17	1,487,000	0.035	0.06	679,000	17
8	1,121,000	0.03	0.065	1,100,000	18
6	357,000	0.025	0.07	1,548,000	36
[/quote]
Deal Fanatic
User avatar
May 2, 2006
8355 posts
2268 upvotes
GTA
raptors87 wrote: should have held RLV

They just put their hand sanitizer on the site today... already sold out

https://www.bioganix.com/products/clean ... -sanitizer
I don't suggest people do what I do, @raptors87. My initial entry was .03 and the avg below .04. The goal is to protect profits/capital. There's always another opportunity lurking.

That said, .045 support is holding well so far and it looks like it might bounce from here.
Deal Addict
Apr 20, 2018
1033 posts
187 upvotes
Oakville, ON
izzyzz wrote: I don't suggest people do what I do, @raptors87. My initial entry was .03 and the avg below .04. The goal is to protect profits/capital. There's always another opportunity lurking.

That said, .045 support is holding well so far and it looks like it might bounce from here.
Oh my bad... I thought you had a price that you want to break even enough to get out ... nevermind what I said
Deal Fanatic
User avatar
May 2, 2006
8355 posts
2268 upvotes
GTA
And of course this happens... LOL

RELEVIUM SECURES NPN NUMBER WITH MANUFACTURING PARTNER AND IS READY TO MARKET BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA

MONTREAL, April 08, 2020 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has secured the natural product number (“NPN”) for the Canadian market and is ready to launch the product for Canadian customers.

Relevium is leveraging product formulation and manufacturing expertise of its integrated supply chain in Montreal to commercialize the newly announced Bioganix® CleanCare hand sanitizers that effectively kills 99.9% of germs and bacteria. The Company, through its local manufacturing partner, has secured Health Canada Natural Product Number (“NPN number”) and will begin accepting pre-sale orders on a first-come, first-served basis.

“In conjunction with our manufacturing partners, we are very pleased to have the opportunity to introduce Bioganix® trusted products into the Canadian market,” stated Aurelio Useche, CEO of Relevium. “Given the recent tensions between Canada and the US due to the scarcity of supply of essential COVID-19 infection prevention products and in order to support local businesses, we have decided to manufacture locally for each market. Our products will be offered initially online, with plans to offer as well through specialty retail brands,” added Mr. Useche as he commented on the Company’s distribution strategy.
Deal Addict
Nov 14, 2006
3149 posts
1952 upvotes
GTA
raptors87 wrote: should have clarify lol ...I meant izzyzz

how did you get those information?
Level 2 with Scotia Bank
Deal Fanatic
User avatar
May 2, 2006
8355 posts
2268 upvotes
GTA
GSI report by SmallCaps Investment Research:

"We reinitiate coverage of Gatekeeper Systems with a buy recommendation and a price target of $0.65, which is 242% above today’s stock price."

https://smallcaps.us/reports/CR_GSI.pdf
Deal Addict
Apr 20, 2018
1033 posts
187 upvotes
Oakville, ON
is that the company with doctors doing video chat?
Deal Fanatic
User avatar
Jun 19, 2001
9537 posts
3186 upvotes
izzyzz wrote: GSI report by SmallCaps Investment Research:

"We reinitiate coverage of Gatekeeper Systems with a buy recommendation and a price target of $0.65, which is 242% above today’s stock price."

https://smallcaps.us/reports/CR_GSI.pdf
Made the mistake of looking into this thread. And I notice the "research report" aka paid ADVERTISING posted there

"Smallcaps Investment Research has been compensated by Gatekeeper Systems Inc. to develop
and execute a communication plan to enhance the Company’s exposure to the investor
community"

which it obviously is, but strangley isn't mentioned

Ths is it for me, keep pumping garbage companies to each other. The promoters love ya
If you aren't willing to take small losses, then you will take big losses. This is my guarantee. -
Mark Minervini
Deal Fanatic
User avatar
May 2, 2006
8355 posts
2268 upvotes
GTA
raptors87 wrote: is that the company with doctors doing video chat?
Video surveillance, analytics, etc.. Have a look at the linked report. It's actually quite good/thorough.
Deal Addict
Jun 23, 2006
1782 posts
247 upvotes
Toronto
zoro69 wrote: Made the mistake of looking into this thread. And I notice the "research report" aka paid ADVERTISING posted there

"Smallcaps Investment Research has been compensated by Gatekeeper Systems Inc. to develop
and execute a communication plan to enhance the Company’s exposure to the investor
community"

which it obviously is, but strangley isn't mentioned

Ths is it for me, keep pumping garbage companies to each other. The promoters love ya
While I do agree that there is a lot of pumping going on in here.. once in a while you do come across a really good pick..

For example I never heard about RLV till I visited this thread and I’m already up %60. And I believe (do your own dd) they will be hitting much higher in the coming weeks and months.

GLTA
Deal Addict
Nov 14, 2006
3149 posts
1952 upvotes
GTA
As I mentioned earlier in thread ATE heading towards ATH leading into trial 2 results.

AGN running nicely as well lately

off topic but my long trade AC ( Air Canada) been running and gapping up daily. Will keep a stop loss as I don't understand this one running in these times

GLA
Deal Fanatic
Apr 18, 2010
5960 posts
1592 upvotes
Toronto
lilmikey wrote:
off topic but my long trade AC ( Air Canada) been running and gapping up daily. Will keep a stop loss as I don't understand this one running in these times
News of them rehiring 16,500 laid off employees greatly strengthening their stock. They're now on payroll but not at active status since there's no work to be done, which leads me to believe this stock should drop again since there's no flights coming out of this airport
Deal Addict
Nov 14, 2006
3149 posts
1952 upvotes
GTA
glover78 wrote: News of them rehiring 16,500 laid off employees greatly strengthening their stock. They're now on payroll but not at active status since there's no work to be done, which leads me to believe this stock should drop again since there's no flights coming out of this airport
I agree, hence tight stop loss since I do as well see it dumping at some point
Jr. Member
Feb 6, 2014
115 posts
1 upvote
Beaverton, ON
Looking for a small cap or penny to throw 50k at. Looking to make small plays, in and out with 10% swings. Any suggestions?
Deal Addict
Nov 14, 2006
3149 posts
1952 upvotes
GTA
AGN News this morning, on a run

Code: Select all

AGNALGERNON PHRMCLCA
$ 0.44
0.15(51.72%)
Bid (Size)0.43 (124)Ask (Size)0.44 (21)Volume1,682,980

Level II Quotes
Orders	Shares	Bid	Ask	Shares	Orders
1	3,500	0.435	0.44	20,500	3
3	53,500	0.43	0.445	19,500	3
3	9,000	0.425	0.45	145,000	5
2	5,500	0.42	0.455	36,000	5
4	13,500	0.415	0.46	7,500	3


Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board
Monday, April 13, 2020, 8:30 AM ET


Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board
VANCOUVER, British Columbia, April 13, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company, is pleased to announce that it has received positive feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's plans to conduct a phase 2 COVID-19 clinical trial using its repurposed drug NP-120 (Ifenprodil).
Based on the feedback, the Company plans to submit, as soon as possible, an Investigational New Drug (IND) application to the FDA, to conduct a Phase 2 clinical trial with Ifenprodil, as a therapy for patients who experience respiratory complications as a result of contracting COVID-19.
"We are very pleased with the expedited response we received from the FDA on our pre-IND application," said Christopher J. Moreau CEO of Algernon. "This is the first time Ifenprodil has been presented to the FDA in a formal process and their response was very encouraging."
The Company is also pleased to announce the appointment of U.S. Ambassador (Rtd) Howard Gutman, former United States Ambassador to Belgium, to the Company's newly created Business Advisory Board.
Ambassador (Rtd) Gutman acted, during his distinguished career over the past three decades, as a leading American and international lawyer, and served in a number of high-profile appointments for the government of the United States, including Ambassador to Belgium, and Special Assistant to the Director of the FBI for Counter-Intelligence and Counter-Terrorism. During his legal career he served as a United States Supreme Court and federal appellate court law clerk prior to entering private practice in Washington, DC., where in addition to legal practice, he served as advisor to candidates for President, Governor and the U.S. Senate.
"Ambassador (Rtd) Gutman is an accomplished diplomat spanning decades of experience in both private and public sectors, and is also a widely-featured commentator, guest speaker and media guest," said Moreau. "He brings a wealth of knowledge and expertise to his advisory position, which will help prepare Algernon as we advance into the next stage of development."
About NP-120 (Ifenprodil)
NP-120 (Ifenprodil) is an N-methyl-D-aspartate (NMDA) receptor antagonist specifically targeting the NMDA-type subunit 2B (Glu2NB). Ifenprodil prevents glutamate signalling. The NMDA receptor is found on many tissues including lung cells and T-cells.
The Company believes NP-120 (Ifenprodil) can reduce the infiltration of neutrophils and T-cells into the lungs where they can each release glutamate and cytokines respectively. The latter can result in the highly problematic cytokine storm that contributes to the loss of lung function and ultimately death as has been reported in COVID-19 infected patients.
Additional Information:
The Company also announces the launch of a new shareholder communications initiative designed to improve visibility into the Company's current and planned operations. The Company has retained South Florida based Midam Ventures LLC (Midam) to assist in the execution of this initiative.
The Company has retained Midam for a period beginning April 8, 2020 and ending on June 30, 2020. For services provided to the Company, Midam has been paid a total cash fee of US $250K. No additional shares, options and or warrants were paid to Midam.
This new shareholder communications initiative is comprehensive and will include text, image & video content disseminated by Midam with the Company retaining full editorial control. Online traffic will be strategically driven to approved content. The program will also include updates to the Company's website and social media initiatives and strategy.
The Company also announces that it has granted, effective April 13, 2020, an aggregate of 4,550,000 stock options (each an "Option") to certain directors, officers, and consultants of the Company in accordance with the Company's stock option plan. Each Option is exercisable into one Share at a price of CDN$0.29 per Share until April 13, 2025. The options have vested immediately and are subject to a 4-month hold.
About Algernon Pharmaceuticals Inc.
Algernon is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon has filed new intellectual property rights globally for NP-120 (Ifenprodil) for the treatment of respiratory diseases and is working to develop a proprietary injectable and slow release formulation.
The Company cautions that it is in the early stages of clinical research and development and is not making any express or implied claims that NP-120 Ifenprodil is an effective treatment for the COVID-19 virus at this time.
CONTACT INFORMATION
Christopher J. Moreau
CEO

Top

Thread Information

There is currently 1 user viewing this thread. (0 members and 1 guest)